Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1570 studies found for:    Lung Diseases, Obstructive: Clinical trials
Show Display Options
Rank Status Study
21 Terminated Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Diabetes;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: inhaled human insulin;   Drug: insulin aspart
22 Terminated The Effect of a Respiratory Muscle Warm-up Prior to Exercise in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Inspiratory Warm Up;   Other: Expiratory Warm Up;   Other: Combination Warm Up;   Other: Control Trial
23 Completed Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD
Condition: COPD
Interventions: Drug: SUN-101 50 mcg BID eFlow (CS) nebulizer;   Drug: SUN-101 25 mcg BID eFlow (CS) nebulizer;   Drug: Placebo BID eFlow Closed System (CS) nebulizer
24 Not yet recruiting The CaNadian Standardized Pulmonary Rehabilitation Efficacy Trial
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Other: Canadian Standardized PR;   Other: Traditional PR
25 Completed A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Fluticasone Propionate/Formoterol Fumarate;   Drug: Formoterol Fumarate;   Drug: Placebo
26 Completed Pilot Randomized Controlled Trial of a Breathlessness Intervention Service for Chronic Obstructive Pulmonary Disease
Condition: Dyspnea
Interventions: Behavioral: Breathlessness Intervention Service (BIS);   Behavioral: Best supportive care (Standard care)
27 Recruiting Rehabilitation of Patients With Lung Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: upper limb exercises;   Other: without training for upper limb
28 Completed Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Fluticasone 500mcg BD via accuhaler or identical placebo
29 Completed
Has Results
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GW642444;   Drug: tiotropium bromide
30 Completed Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Physical activity self-management;   Other: COPD education + Usual care
31 Completed
Has Results
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GSK573719;   Drug: tiotropium bromide
32 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
33 Recruiting A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Rehabilitation
Intervention: Other: Pulmonary Rehabilitation
34 Completed
Has Results
Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Active osteopathic treatment (OMT+PR): Active Comparator;   Other: sham osteopathic treatment (SOT+PR)
35 Completed Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Relaxation Response (instruction, pocket practice card prov);   Behavioral: Mindfulness training using model developed from UMass
36 Completed A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Other: Implementation educational programme
37 Recruiting Clinical Trial Assessing the Value of an Antibiotic Protocol Guided by Serum Procalcitonin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Intensive Care
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Antibiotic therapy randomization;   Other: Serum PCT dosage
38 Not yet recruiting The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Stiolto Respimat;   Drug: Placebo Respimat
39 Completed Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Tiotropium;   Drug: placebo
40 Recruiting Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population
Conditions: Dementia;   Diabetes Mellitus;   Chronic Kidney Disease;   Cardiovascular Diseases;   Malignancy;   Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: 4 x 4 lifestyle modification

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.